Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134156) titled 'A multicenter, prospective, observational real-world study of Etrasimod in the treatment of Chinese adult patients with moderate to severe active ulcerative colitis' on Oct. 11.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The First Affiliated Hospital of Sun Yat-Sen University

Condition: Ulcerative colitis

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-09-22

Target Sample Size: Observation group:100;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=277045

Disclaimer: Curated by HT Syndicat...